The company's U.S., European and South Pacific markets begin the rollout this month with the introduction of the ageLOC Galvanic Body Spa system, while Japan and Korea are both launching ageLOC R2 (R-squared). The products will continue to roll out in additional markets with ageLOC R2 (R-squared) set to launch in the company's Greater China and Southeast Asia markets later this year.
"We are proud to present the latest in ageLOC innovation to our customers and distributors as we continue to solidify our position as a global leader in the anti-aging industry," said Truman Hunt, president and chief executive officer of Nu Skin. "As we launch these new ageLOC products in the United States, Japan, Korea, Europe and South Pacific this month, we continue to see great consumer demand for the ageLOC Galvanic Body Spa and ageLOC R2 (R-squared) and expect the momentum to continue to build through the year."
Both the ageLOC Galvanic Body Spa system and ageLOC R2 (R-squared) were developed utilizing Nu Skin's proprietary ageLOC science that enables the company to identify unique groups of genes specific to the aging process, called Youth Gene Clusters (YGC), and then target and reset them to more youthful patterns of activity. Previous products born out of Nu Skin's exclusive ageLOC science include the ageLOC Galvanic Spa and Gels for the face and the Nu Skin ageLOC® Transformation daily skin care system. The ageLOC super class of anti-aging products has proven to be a tremendous success for Nu Skin, generating sales of more than $700 million over the past three years.
"Our ageLOC scientific approach has brought us to this moment where we can offer people the ageLOC super class of anti-aging products, and our sales are just more proof of how effective people find these products," said Joe Chang, Ph.D., Nu Skin chief scientific officer. "What's more, we believe we have yet to even scratch the surface on what ageLOC is truly capable of in terms of anti-aging science. While we celebrate the introduction of these products, and our recent acquisition of LifeGen Technologies and their more than thirty years of anti-aging genetic research, we are also greatly looking forward to the innovation that lies ahead."
